COST-EFFECTIVENESS ANALYSIS OF FORMOTEROL FOR ASTHMA TREATMENT IN RUSSIAN FEDERATION

被引：0
|
作者：
Kulikov, A. [1 ]
Makarova, E. [1 ]
机构：
[1] IM Sechenov First Moscow State Med Univ, Moscow, Russia
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.456
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRS35
引用
收藏
页码：A115 / A116
页数：2
相关论文
共 50 条
  • [41] A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma
    Stallberg, B.
    Ekstrom, T.
    Neij, F.
    Olsson, P.
    Skoogh, B. -E.
    Wennergren, G.
    Lofdahl, C. -G.
    RESPIRATORY MEDICINE, 2008, 102 (10) : 1360 - 1370
  • [42] Cost-effectiveness of asthma therapy
    Green, R. J.
    SOUTH AFRICAN FAMILY PRACTICE, 2006, 48 (02) : 44 - 47
  • [43] COST-EFFECTIVENESS ANALYSIS OF ANTIEMETIC TREATMENT
    BLEIBERG, H
    AUTIER, P
    MICHAUX, D
    SUPPORTIVE CARE IN CANCER, 1994, 2 (03) : 145 - 149
  • [44] COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF NILOTINIB FOR THE SECOND LINE TRATMENT OF CHRONIC MIELOID LEUKEMIA IN THE RUSSIAN FEDERATION
    Avxentyev, N. A.
    Frolov, M. Y.
    Makarov, A. S.
    VALUE IN HEALTH, 2018, 21 : S29 - S29
  • [45] THE VIRTUAL ASTHMA CLINIC FOR CHILDREN: A COST-EFFECTIVENESS ANALYSIS
    Van den Wijngaart, L. S.
    Kievit, W.
    Roukema, J.
    Boehmer, A. L.
    Brouwer, M. L.
    Hugen, C. A.
    Niers, L. E.
    Sprij, A. J.
    Rikkers-Mutsaerts, E. R.
    Rottier, B. L.
    Verhaak, C. M.
    Pijnenburg, M. W.
    Merkus, P. J.
    PEDIATRIC PULMONOLOGY, 2016, 51 : S65 - S65
  • [46] Cost-effectiveness analysis of an asthma patient education program
    Siracusa, A
    Brugnami, G
    Curradi, F
    Marabini, A
    Anulli, R
    Casciola, G
    Pettinari, L
    Matteucci, G
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A913 - A913
  • [47] A prospective cost-effectiveness analysis for the prevention of asthma in children
    Gutierrez De Mesa, E.
    Hidalgo, I.
    Christidis, P.
    Ciscar, Jc
    Vegas, E.
    Ibarreta, D.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2006, 16 : 137 - 137
  • [48] TREATMENT OF MODERATE-TO-SEVERE ACTIVE PSORIATIC ARTHRITIS: COST-EFFECTIVENESS ANALYSIS AND BUDGET IMPACT ANALYSIS OF BIOLOGICS AND TARGETED THERAPIES APPROVED IN THE RUSSIAN FEDERATION
    Rudakova, A.
    Tolkacheva, D.
    Sokolova, V
    VALUE IN HEALTH, 2022, 25 (01) : S117 - S118
  • [49] Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma:: an efficacy and cost-effectiveness study
    Lundborg, Mikael
    Wille, Soren
    Bjermer, Leif
    Tilling, Bjorn
    Lundgren, Michael
    Telg, Gunilla
    Ekstrom, Tommy
    Selroos, Olof
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (05) : 809 - 821
  • [50] COST-EFFECTIVENESS OF ATYPICAL ANTIPSYCHOTICS (QUETIAPINE, RISPERIDONE, ARIPIPRAZOLE OR OLANZAPINE) FOR THE TREATMENT OF RELAPSE PREVENTION FOR BIPOLAR DISORDER IN RUSSIAN FEDERATION
    Komarov, I.
    Kulikov, A.
    EUROPEAN PSYCHIATRY, 2014, 29
12345